Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Wegovy pill is the UK's first oral GLP-1 medicine licensed for weight management — a once-daily semaglutide tablet approved by the MHRA on 11 June 2026. It is a prescription-only medicine, which means a clinician must assess your suitability before any supply. Here is a clear, step-by-step account of how the tablet works, who it is licensed for, and how a regulated online service can bring it to your door.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide does not absorb reliably through the gut wall on its own, so the Wegovy pill pairs it with a compound called SNAC, which temporarily changes the local environment in the stomach to allow absorption. That is the core engineering challenge the tablet solves, and it is why the tablet has to be taken on a completely empty stomach, any food or drink (other than a small amount of plain water) in the stomach disrupts the process.
Once absorbed, semaglutide acts on GLP-1 receptors involved in appetite regulation and the feeling of fullness. Gastric emptying slows, hunger signals quieten, and most people find they are satisfied with smaller meals. The NHS medicines page for semaglutide explains the mechanism and common effects in plain language worth reading before you start.
One thing our prescribers hear most weeks: patients asking whether the tablet is "weaker" than the injection. The short answer is no. The maintenance dose is 25mg once daily, titrated up from 1.5mg, and the trial results at full dose are in the same territory as the 2.4mg injection, it is a different delivery system, not a lesser one. You can read more about how the formats compare on our Wegovy as a pill overview.
The escalation runs: 1.5mg for at least one month, then 4mg, then 9mg, then 25mg at maintenance. Each step gives your system time to settle before the dose rises. Patients who are already established on the 2.4mg injection may be able to move directly to the 25mg tablet, but that decision sits with your prescriber after a clinical review.
The daily routine is straightforward once it becomes habit. First thing in the morning, before the kettle goes on, you take the tablet with no more than a small sip of plain water. Then you wait at least 30 minutes before any food, coffee, or other oral medicine. The tablet should be swallowed whole. That window is non-negotiable, it is the gap that makes absorption possible. For the exact dosing details and the full list of instructions, the prescribing information published on the Medicines and Healthcare products Regulatory Agency's products database is the definitive source.
No fridge required. Room-temperature storage makes the tablet genuinely travel-friendly in a way the injection is not. If you are curious about how the pill format differs from the pen day to day, that page goes into more practical detail.
The MHRA licence covers adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, or obstructive sleep apnoea. A BMI figure alone does not confirm suitability, a prescriber reviews the whole picture, including your medical history, current medicines, and any conditions that would make treatment unsuitable.
The Wegovy pill is not licensed for use in pregnancy, while breastfeeding, or for anyone trying to conceive. People under 18 are also outside the licensed population. Certain conditions, including a personal or family history of medullary thyroid carcinoma and a history of pancreatitis, require careful prescriber assessment. The NICE appraisal of semaglutide for weight management (TA875) provides the broader clinical framework, though a specific NICE appraisal for the oral tablet has not yet been published at the time of writing.
The Wegovy pill is not currently available on the NHS. A NICE appraisal would be needed before NHS commissioning could begin, so for now it is available only through private prescription. Our Wegovy tablet pricing page sets out what a private prescription route involves in terms of cost.
Buying a prescription medicine online is legal and safe when the pharmacy is registered with the General Pharmaceutical Council. The GPhC maintains a public register where you can verify any pharmacy by its premises registration number, it takes about 30 seconds and is worth doing for any service you are considering. For context on what a legitimate service looks like, our about us page sets out how our pharmacy is regulated and how every consultation is reviewed.
At nume, the process runs like this. You complete a free consultation, questions about your health, medicines, and weight history. A GPhC-registered Independent Prescriber reads your answers the same day. If treatment is clinically suitable, your prescription is written, your medicine is dispensed, and it leaves our pharmacy the same day if you ordered by 12pm. DPD delivers it to your door the following working day in plain, unbranded packaging. No subscription, no auto-renewal, every repeat order goes through clinical review again.
The MHRA has warned publicly about semaglutide and other weight-loss medicines being sold through social media and unverified websites, sometimes without any clinical assessment. Fake products have caused hospitalisations. The only safe route to a prescription medicine is through a prescriber who has properly assessed you and a pharmacy you can verify. If you want to explore your options, our semaglutide tablets online page covers the access picture in full, and our weight-loss treatments page is where you can start a free consultation with our clinical team.
If you have questions before you begin, our FAQs cover the most common ones, and you can always reach our prescribers directly through the contact page. For a broader look at the oral tablet, the Wegovy pill guide and our semaglutide tablets overview are good next reads. Our clinical lead's profile is on the Mostafa Damghani page if you want to know more about the team behind the service.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.